---
title: "MGL New Materials released its performance for the first three quarters, with a net profit attributable to the parent company of 7.3271 million yuan, a decrease of 18.87%"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/263240654.md"
description: "MGL New Materials released its Q3 2025 report, with operating revenue for the first three quarters amounting to 1.63 billion yuan, a year-on-year increase of 24.22%. The net profit attributable to the parent company was 7.3271 million yuan, a year-on-year decrease of 18.87%; the net profit excluding non-recurring gains and losses was 9.7906 million yuan, a year-on-year increase of 64.13%. The basic earnings per share were 0.0159 yuan"
datetime: "2025-10-29T08:41:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263240654.md)
  - [en](https://longbridge.com/en/news/263240654.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263240654.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/263240654.md) | [繁體中文](https://longbridge.com/zh-HK/news/263240654.md)


# MGL New Materials released its performance for the first three quarters, with a net profit attributable to the parent company of 7.3271 million yuan, a decrease of 18.87%

According to the Zhitong Finance APP, MGL New Materials (301487.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 1.63 billion yuan, a year-on-year increase of 24.22%. The net profit attributable to shareholders of the listed company was 7.3271 million yuan, a year-on-year decrease of 18.87%. The net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 9.7906 million yuan, a year-on-year increase of 64.13%. The basic earnings per share were 0.0159 yuan

### 相关股票

- [MGL New Materials (301487.CN)](https://longbridge.com/zh-CN/quote/301487.CN.md)

## 相关资讯与研究

- [08:54 ETNew Research Claims to Show Bioavailability of Oral Liposomal Glutathione. But does it really?](https://longbridge.com/zh-CN/news/281371900.md)
- [Cosigo Resources Extends Private Placement to Advance Gold Exploration Assets](https://longbridge.com/zh-CN/news/281460385.md)
- [Ganfeng Lithium Turns to 2025 Profit](https://longbridge.com/zh-CN/news/281121946.md)
- [California's top lawyer explains why he hasn't sued Kalshi like Nevada and Arizona](https://longbridge.com/zh-CN/news/281499429.md)
- [Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst⢠(bumetanide nasal spray)](https://longbridge.com/zh-CN/news/281570860.md)